Myeloma stem cell phenotype: Implications for treatment

Hematology/Oncology Clinics of North America

Volumn 11, Issue 1, 1997, Pages 43-49

  Epstein, J ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; B LYMPHOCYTE; CELL DIFFERENTIATION; HEMATOPOIETIC STEM CELL; HUMAN; MULTIPLE MYELOMA; PLASMA CELL; PRIORITY JOURNAL;

EID: 0030934954     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8588(05)70414-7     Document Type: Article

References (38)

1. B. Barlogie J. Epstein Multiple myeloma: Biology and therapy J Cancer Res Clin Oncol 116 1990 109
2. B. Barlogie J. Epstein P. Selvanayagam R. Alexanian Plasma cell myeloma—new biological insights and advances in therapy [review] Blood 73 1989 865
3. R. Bataille B. Barlogie Z.Y. Lu Biologic effects of anti–interleukin-6 murine monoclonal antibody in advanced multiple myeloma Blood 86 1995 685
4. A.R. Belch P.L. Bergsagel A. Szczepek CD34+ B-cells in the blood of patients with multiple myeloma express clonotypic IgH sequences Blood 84 A 385 1994
5. P.L. Bergsagel A.R. Belch L.M. Pilarski The blood B cells and bone marrow plasma cells in a patient with multiple myeloma include cells with the same N-ras mutation Blood 84 suppl 1 1994 524a
6. L. Bergui M. Schena G. Gaidano Interleukin 3 and interleukin 6 synergistically promote the proliferation and differentiation of malignant plasma cell precursors in multiple myeloma J Exp Med 170 1989 613
7. D. Billadeau G. Ahmann Greipp P. van Ness B. The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell J Exp Med 178 1993 1023
8. D. Billadeau M. Blackstadt P. Greipp Analysis of B-lymphoid malignancies using allele-specific polymerase chain reaction: A technique for sequential quantitation of residual disease Blood 78 1991 3021
9. F. Caligaris-Cappio L. Bergui M.G. Gregoretti Role of bone marrow stromal cells in the growth of human multiple myeloma Blood 77 1991 2688
10. F. Caligaris-Cappio L. Bergui L. Tesio Identification of malignant plasma cell precursors in the bone marrow of multiple myeloma J Clin Invest 76 1985 1243
11. B.J. Chen J. Epstein Circulating clonal lymphocytes in myeloma constitute a minor subpopulation of B cells Blood 87 1996 1972
12. P. Corradini M. Boccadoro C. Voena A. Pileri Evidence for a bone marrow B cell transcribing malignant plasma cell VDJ joined to C mu sequence in immunoglobulin (IgG)- and IgA-secreting multiple myelomas J Exp Med 178 1993 1091
13. D.D. Dao J.R. Sawyer J. Epstein Deletion of the retinoblastoma gene in multiple myeloma Leukemia 8 1994 1280
14. de Hon F.D. M. Ehlers S. Rose-John Development of an interleukin (IL) 6 receptor antagonist that inhibits IL-6–dependent growth of human myeloma cells J Exp Med 180 1994 2395
15. B.G. Durie T.M. Grogan CALLA-positive myeloma: An aggressive subtype with poor survival Blood 66 1985 229
16. J. Epstein B. Barlogie J. Katzmann R. Alexanian Phenotypic heterogeneity in aneuploid multiple myeloma indicates pre-B cell involvement Blood 71 1988 861
17. Y. Gazitt C.C. Reading R. Hoffman Purified CD34+ Lin− Thy+ stem cells do not contain clonal myeloma cells Blood 86 1995 381
18. Y. Gazitt E. Tian B. Barlogie Differential mobilization of myeloma cells and normal hematopoietic stem cells in multiple myeloma after treatment with cyclophosphamide and granulocyte-macrophage colony-stimulating factor Blood 87 1996 805
19. I. Grigorieva J. Woodliff S.L. MacLeod Interleukin-6 negates the cytotoxicity of dexamethasone in myeloma [meeting abstract] Proc Annu Meet Am Assoc Cancer Res 36 1995 A128
20. T.M. Grogan B.G. Durie C. Lomen Delineation of a novel pre-B cell component in plasma cell myeloma: Immunochemical, immunophenotypic, genotypic, cytologic, cell culture, and kinetic features Blood 70 1987 932
21. J. Hardin S. MacLeod I. Grigorieva Interleukin-6 prevents dexamethasone-induced myeloma cell death Blood 84 1994 3063
22. H. Hata H. Xiao M.T. Petrucci Interleukin-6 gene expression in multiple myeloma: A characteristic of immature tumor cells Blood 81 1993 3357
23. G.S. Jensen M.J. Mant A.J. Belch Selective expression of CD45 isoforms defines CALLA+ monoclonal B-lineage cells in peripheral blood from myeloma patients as late stage B cells Blood 78 1991 711
24. G.S. Jensen M.J. Mant L.M. Pilarski Sequential maturation stages of monoclonal B lineage cells from blood, spleen, lymph node, and bone marrow from a terminal myeloma patient Am J Hematol 41 1992 199
25. D. Joshua A. Petersen R. Brown The labelling index of primitive plasma cells determines the clinical behaviour of patients with myelomatosis Br J Haematol 94 1996 76
26. M.M. Kawano N. Huang H. Harada Identification of immature and mature myeloma cells in the bone marrow of human myelomas Blood 82 1993 564
27. M.M. Kawano M.S. Mahmoud N. Huang High proportions of VLA-5–immature myeloma cells correlated well with poor response to treatment in multiple myeloma Br J Haematol 91 1995 860
28. H. Kubagawa L.B. Vogler J.D. Capra Studies on the clonal origin of multiple myeloma. Use of individually specific (idiotype) antibodies to trace the oncogenic event to its earliest point of expression in B-cell differentiation J Exp Med 150 1979 792
29. A. Lichtenstein Y. Tu C. Fady Interleukin-6 inhibits apoptosis of malignant plasma cells Cell Immunol 162 1995 248
30. P. Omede M. Boccadoro A. Fusaro Multiple myeloma: `Early' plasma cell phenotype identifies patients with aggressive biological and clinical characteristics Br J Haematol 85 1993 504
31. M. Sailer K.F. Vykoupil D. Peest Prognostic relevance of a histologic classification system applied in bone marrow biopsies from patients with multiple myeloma: A histopathological evaluation of biopsies from 153 untreated patients Eur J Haematol 54 1995 137
32. R. Savino L. Ciapponi A. Lahm Rational design of a receptor super-antagonist of human interleukin-6 EMBO J 13 1994 5863
33. M. Sawamura H. Murakami J. Tamura Tumour necrosis factor-alpha and interleukin 4 promote the differentiation of myeloma cell precursors in multiple myeloma Br J Haematol 88 1996 17
34. X. Thomas H.Q. Xiao R. Chang J. Epstein Circulating B lymphocytes in multiple myeloma patients contain an autocrine IL-6 driven pre-myeloma cell population Curr Top Microbiol Immunol 182 1992 201
35. van Oers M.H. van Zaanen H.C. H.M. Lokhorst Interleukin-6, a new target for therapy in multiple myeloma? [review] Ann Hematol 66 1993 219
36. R.A. Vescio C.H. Hong J. Cao The hematopoietic stem cell antigen, CD34, is not expressed on the malignant cells in multiple myeloma Blood 84 1994 3283
37. D.H. Vesole S. Jagannath G. Tricot Autologous bone marrow and peripheral blood stem cell transplantation in multiple myeloma Cancer Invest 14 1996 378
38. D.H. Vesole G. Tricot S. Jagannath Autotransplants in multiple myeloma—what have we learned? Blood 88 1996 838